• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Schein recruitment!









Surprised they would make the move. The techs at our branch were averaging a call a day and would complain if they had to make 2. Will actually have to work at Schein since they've taken most of the business.